Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
71 Cards in this Set
- Front
- Back
Major effects of the RAS system
|
Maintain BP, salt & water balance
|
|
Minor effects of the RAS system
|
Vasoconstriction
Role in inflammation |
|
RAS is composed of a ________ and a _________ system
|
Systemic (vascular)
Local (tissue) |
|
RAS is involved in long-term or short-term regulation of BP?
|
Both - long term and short term
|
|
Precursor protein for the family of angiotensin peptides (the RAS)
|
Angiotensinogen
|
|
Earlier names for angiotensinogen protein (2)
|
Angiotonin
Hypertensin |
|
Main function of angiotensinogen:
|
It is the rate-limiting factor in the activity of the systemic renin angiotensin system
|
|
Angiotensinogein is primarily synthesized in what type of cells?
|
Hepatocytes
|
|
Other sites of synthesis for angiotensinogen (not the primary site):
|
CNS, heart, vasculature, kidney, adipocytes
|
|
Is angiotensinogen stored in the body?
|
No, it is constantly made and secreted.
|
|
What is the form of angiotensinogen in circulation?
|
Pre-pro-angiotensinogen
|
|
How do adipose tissue and estrogen from hepatocytes regulate the production of angiotensinogen?
|
Upregulate production by upregulating the mRNA.
|
|
Angiotensinogen is transcriptionally controlled via specific regulatory DNA sequences of its gene by which substances?
|
Glucocorticoids, estrogen, thyroid hormone, insulin, some cytokines
|
|
Glucocorticoids, estrogen, thyroid hormone, insulin, and select cytokines have what affect on angiotensinogen?
|
Control its release from producing cells by affecting the angiotensinogen gene on a transcriptional level
|
|
What enzyme cleaves angiotensinogen, where does the cleavage occur, and what product results?
|
Cleaved by renin;
Cleaved in circulation; Produces Ang I, an N-terminal decapeptide |
|
What effect does Ang II have on release of angiotensinogen?
|
Angiotensinogen synthesis can be stimulated by Ang II
|
|
What effect does inflammation have on release of angiotensinogen?
|
Release is stimulated by inflammation
|
|
By what mechanism does Ang II exert positive feedback regulation on the release of angiotensinogen?
|
Via an AT1 (Angiotensin 1) receptor
|
|
What is the genetic evidence that suggests that angiotensinogen contributes to the hypertensive phenotype?
|
Knockout studies in animals;
Polymorphisms within the angiotensinogen gene have been genetically linked with familial HTN |
|
A highly substrate- and species-specific aspartyl protease enzyme
|
Renin
|
|
What enzyme catalyzes the rate limiting step in the RAS system?
|
Renin
|
|
Name the three molecules of the RAS cascade and the two enzymes that catalyze their transformations
|
Angiotensinogen --> Angiotensin I (catalyzed by Renin);
Angiotensin II --> Angiotensin II (catalyzed by ACE) |
|
What cells are the systemic source for renin synthesis, storage, and release? Where are they located?
|
Juxtaglomerular cells; located in the afferent arteriole
|
|
What is the first step in the synthesis of renin?
|
The formation of pro-pre-renin
|
|
What enzyme mediates the cleavage & activation of renin from pro-pre-renin?
|
Cathepsin B
|
|
How is renin stored and how is it released?
|
It is stored in granules in the juxtaglomerular cells and released through exocytosis into the vascular lumen
|
|
The secretion of renin from the juxtaglomerular cells is regulated primarily by what three pathways?
|
1. Macula densa pathway (kidney)
2. Intrarenal baroreceptor pathway (kidney) 3. Beta-adrenergic receptor pathway (nervous system) |
|
What is the macula densa and where in the kidney is it located?
|
It is a modified plaque of cells, located in the distal tubule of the nephron, at the end of the loop of Henle and adjacent to the afferent arteriole and the juxtaglomerular cells
|
|
What substance is sensed/monitored by the macula densa? What does a change in this substance initiate?
|
Sodium levels. Decreased Na+ levels initiate a cascade of events that ultimately stimulates renin release
|
|
PGE2 and Cox 2 inhibit or stimulate renin release?
|
Stimulate
|
|
Adenosine inhibits or stimulates renin release?
|
Inhibits
|
|
What is the most powerful regulator of renin release?
|
BP, via the intrarenal baroreceptor pathway
|
|
The renal baroreceptor inhibits or stimulates renin release in response to reduced renal perfusion pressure?
|
Stimulates
|
|
The juxtaglomerular cells are directly innervated via the sympathetic nerves. Direct stimulation of these nerves will increase or decrease renin release?
|
Increase
|
|
Ang II inhibits or stimulates renin release?
|
Inhibits
|
|
By what two pathways does Ang II regulate renin release? Hint: one is a short-loop negative feedback system and one is a long-loop negative feedback system
|
Ang II stimulates AT1R...
Short-loop: on the JC cells to inhibit renin release Long-loop: to increase BP, which inhibits renin release |
|
cAMP (stimulates/inhibits) renin release and cGMP (stimulates/inhibits) renin release
|
cAMP: stimulates
cGMP: inhibits |
|
An increase in intracellular calcium (stimulates/inhibits) renin release
|
Inhibits
Increasing cytosolic Ca++ leads to a decrease in cAMP. |
|
An enzyme found in plasma, but that is membrane-bound to endothelial & epithelial cells
|
ACE (angiotensin converting enzyme)
|
|
What is the preferred substrate of ACE, and what effect does ACE have on it?
|
Bradykinins - ACE inactivates.
|
|
An alternative pathway to ACE that converts Ang I to Ang II
|
Chymase enzyme
|
|
Where is ACE predominantly found?
|
On endothelial cells in the lung, retina, and brain; on epithelial cells in the kidney and gut
|
|
What is the function of the ACE 2 enzyme?
|
Catalyzes the formation of Ang 1-7, a vasodilator molecule, from both Ang I and Ang II
|
|
Is ACE 2 susceptible to ACE inhibitors?
|
No.
|
|
What are the two specific receptors for Ang II and which is most common?
|
AT1R and AT2R; AT1R is most common, AT2R is widely distributed in fetal (developmental) tissues
|
|
What are the functions of the AT2 receptors?
|
Oppose actions of Ang II on AT1 receptors: vasodilate, anti-proliferative
|
|
How do ACE inhibitors protect the CV system?
|
They block degradation of Ang 1-7, which can inhibit Ang II actions, to vasodilate; they increase bradykinin, which also vasodilates; they increase ACE 2 levels and subsequently increase Ang 1-7 levels.
|
|
Ang II is not only produced via the endocrine RAS, but is also produced via ____________ in local systems
|
Paracrine/autocrine
|
|
What actions can locally-formed angiotensins have (as opposed to systemically formed)
|
Growth factors, neurotransmitters, smooth muscle constrictors.
|
|
What are two local systems where the RAS is found and what specific function might they have there?
|
Skin - may be involved in wound healing since Ang II levels are increased after injury
Pancreas - strong association with high levels of ACE and pancreatic disfunction with obesity, HTN, and diabetes |
|
What are the major roles of Ang II?
|
Regulation of BP and salt & volume homeostasis
|
|
What effect does Ang II have on TPR?
|
Increases, via direct & indirect effects
|
|
How does Ang II affect cardiovascular STRUCTURE?
|
Stimulates hypertrophy of VSM:
a. Hemodynamically by increasing pressure b. Nonhemodynamically by stimulating growth factors Remodeling: collagen formation Vasoconstriction of VSM Mitogenesis of VSM |
|
RAS contribution to disease states other than CV
|
Atherosclerosis: oxidative stress & pro-inflammatory effects
Generation of reactive oxygen species: increase in free radicals leads to endothelial dysfunction Pro-thrombotic effects: stimulation of plasminogen activator inhibitor (PAI breaks down plasmin, plasmin breaks down clots) |
|
How might the RAS effects on thrombotic events correlate to its overall function?
|
RAS controls BP. Hemorrhage affects BP. Clotting stops bleeding and helps maintain BP when hemorrhaging, but when there is no hemorrhagic event, the RAS inhibition of dissolving clots is a problem.
|
|
Ang II may act as a _________, which relates to its pro-inflammation effects as a growth promotor and a pro-inflammatory modulator
|
Cytokine
|
|
One of the pro-inflammatory effects of Ang II is that is can recruit cells. Which type of cells responds to Ang II?
|
Monocytes.
|
|
Ang II, along with potassium, regulates the secretion of what steroid?
|
Aldosterone
|
|
Where is aldosterone produced and where in the body?
|
In the zona glomerulosa of the adrenal cortex
|
|
What type of steroid is aldosterone?
|
Mineralocorticoid
|
|
What is the major function of aldosterone?
|
To act on renal & other epithelia to enhance sodium reabsorption & increase the excretion of potassium & hydrogen ions
|
|
What are some trtmts for HTN that involve the RAS?
|
Renin inhibitors
ACE inhibitors AT1R antagonists ACE2/AT2R/Ang 1-7 agonists |
|
Why are ACE inhibitors and ARB (AT1R antagonists) contraindicated in pregnant women?
|
They can affect developmental of fetal organs, including the kidney
|
|
In the HOPE study, ACE inhibitors were shown to reduce MIs in pts with CV disease. What were the effects of ACE I on:
Cardiac hypertrophy: Ang II: Plasmin levels: Platelets: Bradykinin: Ang 1-7: ACE 2: Blood pressure: |
Reduce cardiac hypertrophy
Decrease Ang II (& hence PAI-1, which increases plasmin levels & breaks down clots) Reduce platelet action Increase bradykinin levels Increase levels of Ang 1-7 & ACE2 Reduce BP & hence decrease load on heart |
|
The discovery of what receptors in 2007 is leading to a new class of antihypertensive agents?
|
The prorenin receptor
|
|
What is the new renin inhibitor for the prorenin receptor?
|
Aliskiren
|
|
T/F: Aliskiren binds only prorenin on tissues
|
False. It binds renin and prorenin, but the ratio of renin to prorenin is 1:7 in normal individuals
|
|
What effect does an overexpression of prorenin receptors have in transgenic mice?
|
Increased BP
|
|
What series of intracellular events is triggered by the activation of the prorenin receptors?
|
1. Activation of PAI-1
2. Activation of fibrotic extracellular components such as fibronectin & collagen 3. Increases levels of TGF-beta |
|
What does the effect of the activation of prorenin receptors on levels of TGF-beta suggest?
|
Increased levels of TGF-beta suggest that renin may contribute to hypertrophy & fibrosis, independent of Ang II action or generation
|
|
What angiotensin peptide has been discovered in 2008, that is another angiotensin precursor?
|
Angiotensin 1-12
|